Global Prurigo Nodularis Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prurigo Nodularis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Capsaicin Cream
1.2.3 Antihistamines
1.2.4 Others
1.3 Market by Application
1.3.1 Global Prurigo Nodularis Treatment Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Prurigo Nodularis Treatment Market Size (2017-2028)
2.2 Prurigo Nodularis Treatment Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Prurigo Nodularis Treatment Market Size by Region (2017-2022)
2.4 Global Prurigo Nodularis Treatment Market Size Forecast by Region (2023-2028)
2.5 Global Top Prurigo Nodularis Treatment Countries Ranking by Market Size
3 Prurigo Nodularis Treatment Competitive by Company
3.1 Global Prurigo Nodularis Treatment Revenue by Players
3.1.1 Global Prurigo Nodularis Treatment Revenue by Players (2017-2022)
3.1.2 Global Prurigo Nodularis Treatment Market Share by Players (2017-2022)
3.2 Global Prurigo Nodularis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Prurigo Nodularis Treatment Revenue
3.4 Global Prurigo Nodularis Treatment Market Concentration Ratio
3.4.1 Global Prurigo Nodularis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prurigo Nodularis Treatment Revenue in 2021
3.5 Global Prurigo Nodularis Treatment Key Players Head office and Area Served
3.6 Key Players Prurigo Nodularis Treatment Product Solution and Service
3.7 Date of Enter into Prurigo Nodularis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Prurigo Nodularis Treatment Breakdown Data by Type
4.1 Global Prurigo Nodularis Treatment Historic Revenue by Type (2017-2022)
4.2 Global Prurigo Nodularis Treatment Forecasted Revenue by Type (2023-2028)
5 Global Prurigo Nodularis Treatment Breakdown Data by Application
5.1 Global Prurigo Nodularis Treatment Historic Market Size by Application (2017-2022)
5.2 Global Prurigo Nodularis Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Prurigo Nodularis Treatment Revenue by Company (2020-2022)
6.2 North America Prurigo Nodularis Treatment Revenue by Type (2017-2028)
6.3 North America Prurigo Nodularis Treatment Revenue by Application (2017-2028)
6.4 North America Prurigo Nodularis Treatment Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Prurigo Nodularis Treatment Revenue by Company (2020-2022)
7.2 Europe Prurigo Nodularis Treatment Revenue by Type (2017-2028)
7.3 Europe Prurigo Nodularis Treatment Revenue by Application (2017-2028)
7.4 Europe Prurigo Nodularis Treatment Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Prurigo Nodularis Treatment Revenue by Company (2020-2022)
8.2 Asia Pacific Prurigo Nodularis Treatment Revenue by Type (2017-2028)
8.3 Asia Pacific Prurigo Nodularis Treatment Revenue by Application (2017-2028)
8.4 Asia Pacific Prurigo Nodularis Treatment Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Prurigo Nodularis Treatment Revenue by Company (2020-2022)
9.2 Latin America Prurigo Nodularis Treatment Revenue by Type (2017-2028)
9.3 Latin America Prurigo Nodularis Treatment Revenue by Application (2017-2028)
9.4 Latin America Prurigo Nodularis Treatment Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prurigo Nodularis Treatment Revenue by Company (2020-2022)
10.2 Middle East and Africa Prurigo Nodularis Treatment Revenue by Type (2017-2028)
10.3 Middle East and Africa Prurigo Nodularis Treatment Revenue by Application (2017-2028)
10.4 Middle East and Africa Prurigo Nodularis Treatment Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Prurigo Nodularis Treatment Products and Services
11.1.4 Johnson & Johnson Prurigo Nodularis Treatment Revenue in Prurigo Nodularis Treatment Business (2017-2022)
11.1.5 Johnson & Johnson Prurigo Nodularis Treatment SWOT Analysis
11.1.6 Johnson & Johnson Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Prurigo Nodularis Treatment Products and Services
11.2.4 GlaxoSmithKline Prurigo Nodularis Treatment Revenue in Prurigo Nodularis Treatment Business (2017-2022)
11.2.5 GlaxoSmithKline Prurigo Nodularis Treatment SWOT Analysis
11.2.6 GlaxoSmithKline Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Prurigo Nodularis Treatment Products and Services
11.3.4 Pfizer Prurigo Nodularis Treatment Revenue in Prurigo Nodularis Treatment Business (2017-2022)
11.3.5 Pfizer Prurigo Nodularis Treatment SWOT Analysis
11.3.6 Pfizer Recent Developments
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Prurigo Nodularis Treatment Products and Services
11.4.4 Teva Pharmaceutical Prurigo Nodularis Treatment Revenue in Prurigo Nodularis Treatment Business (2017-2022)
11.4.5 Teva Pharmaceutical Prurigo Nodularis Treatment SWOT Analysis
11.4.6 Teva Pharmaceutical Recent Developments
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Prurigo Nodularis Treatment Products and Services
11.5.4 Bayer Prurigo Nodularis Treatment Revenue in Prurigo Nodularis Treatment Business (2017-2022)
11.5.5 Bayer Prurigo Nodularis Treatment SWOT Analysis
11.5.6 Bayer Recent Developments
12 Prurigo Nodularis Treatment Market Dynamics
12.1 Prurigo Nodularis Treatment Market Trends
12.2 Prurigo Nodularis Treatment Market Drivers
12.3 Prurigo Nodularis Treatment Market Challenges
12.4 Prurigo Nodularis Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Prurigo Nodularis Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Capsaicin Cream
Table 3. Key Players of Antihistamines
Table 4. Key Players of Others
Table 5. Global Prurigo Nodularis Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Prurigo Nodularis Treatment Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Prurigo Nodularis Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Prurigo Nodularis Treatment Revenue Market Share by Region (2017-2022)
Table 9. Global Prurigo Nodularis Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Prurigo Nodularis Treatment Market Share by Players (2017-2022)
Table 11. Global Top Prurigo Nodularis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prurigo Nodularis Treatment as of 2021)
Table 12. Ranking of Global Top Prurigo Nodularis Treatment Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Prurigo Nodularis Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Prurigo Nodularis Treatment Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Prurigo Nodularis Treatment Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Prurigo Nodularis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Prurigo Nodularis Treatment Revenue Market Share by Type (2017-2022)
Table 20. Global Prurigo Nodularis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Prurigo Nodularis Treatment Revenue Market Share by Type (2023-2028)
Table 22. Global Prurigo Nodularis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Prurigo Nodularis Treatment Revenue Market Share by Application (2017-2022)
Table 24. Global Prurigo Nodularis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Prurigo Nodularis Treatment Revenue Market Share by Application (2023-2028)
Table 26. North America Prurigo Nodularis Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Prurigo Nodularis Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Prurigo Nodularis Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Prurigo Nodularis Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Prurigo Nodularis Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Prurigo Nodularis Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Prurigo Nodularis Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Prurigo Nodularis Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Prurigo Nodularis Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Prurigo Nodularis Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Prurigo Nodularis Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Prurigo Nodularis Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Prurigo Nodularis Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Prurigo Nodularis Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Prurigo Nodularis Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Prurigo Nodularis Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Prurigo Nodularis Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Prurigo Nodularis Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Prurigo Nodularis Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Prurigo Nodularis Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Prurigo Nodularis Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Prurigo Nodularis Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Prurigo Nodularis Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Prurigo Nodularis Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Prurigo Nodularis Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Prurigo Nodularis Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Prurigo Nodularis Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Prurigo Nodularis Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Prurigo Nodularis Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Prurigo Nodularis Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Prurigo Nodularis Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Prurigo Nodularis Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Prurigo Nodularis Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Prurigo Nodularis Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Prurigo Nodularis Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 61. Johnson & Johnson Company Details
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Prurigo Nodularis Treatment Product and Services
Table 64. Johnson & Johnson Prurigo Nodularis Treatment Revenue in Prurigo Nodularis Treatment Business (2017-2022) & (US$ Million)
Table 65. Johnson & Johnson Prurigo Nodularis Treatment SWOT Analysis
Table 66. Johnson & Johnson Recent Developments
Table 67. GlaxoSmithKline Company Details
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Prurigo Nodularis Treatment Product and Services
Table 70. GlaxoSmithKline Prurigo Nodularis Treatment Revenue in Prurigo Nodularis Treatment Business (2017-2022) & (US$ Million)
Table 71. GlaxoSmithKline Prurigo Nodularis Treatment SWOT Analysis
Table 72. GlaxoSmithKline Recent Developments
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Prurigo Nodularis Treatment Product and Services
Table 76. Pfizer Prurigo Nodularis Treatment Revenue in Prurigo Nodularis Treatment Business (2017-2022) & (US$ Million)
Table 77. Pfizer Prurigo Nodularis Treatment SWOT Analysis
Table 78. Pfizer Recent Developments
Table 79. Teva Pharmaceutical Company Details
Table 80. Teva Pharmaceutical Business Overview
Table 81. Teva Pharmaceutical Prurigo Nodularis Treatment Product and Services
Table 82. Teva Pharmaceutical Prurigo Nodularis Treatment Revenue in Prurigo Nodularis Treatment Business (2017-2022) & (US$ Million)
Table 83. Teva Pharmaceutical Prurigo Nodularis Treatment SWOT Analysis
Table 84. Teva Pharmaceutical Recent Developments
Table 85. Bayer Company Details
Table 86. Bayer Business Overview
Table 87. Bayer Prurigo Nodularis Treatment Product and Services
Table 88. Bayer Prurigo Nodularis Treatment Revenue in Prurigo Nodularis Treatment Business (2017-2022) & (US$ Million)
Table 89. Bayer Prurigo Nodularis Treatment SWOT Analysis
Table 90. Bayer Recent Developments
Table 91. Prurigo Nodularis Treatment Market Trends
Table 92. Prurigo Nodularis Treatment Market Drivers
Table 93. Prurigo Nodularis Treatment Market Challenges
Table 94. Prurigo Nodularis Treatment Market Restraints
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Prurigo Nodularis Treatment Sales Market Share by Type: 2021 VS 2028
Figure 2. Capsaicin Cream Features
Figure 3. Antihistamines Features
Figure 4. Others Features
Figure 5. Global Prurigo Nodularis Treatment Sales Market Share by Application: 2021 VS 2028
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Prurigo Nodularis Treatment Report Years Considered
Figure 10. Global Prurigo Nodularis Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Prurigo Nodularis Treatment Market Size 2017-2028 (US$ Million)
Figure 12. Global Prurigo Nodularis Treatment Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Prurigo Nodularis Treatment Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Prurigo Nodularis Treatment Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Prurigo Nodularis Treatment Market Share by Players in 2021
Figure 16. Global Top Prurigo Nodularis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prurigo Nodularis Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Prurigo Nodularis Treatment Revenue in 2021
Figure 18. North America Prurigo Nodularis Treatment Revenue Market Share by Company in 2021
Figure 19. North America Prurigo Nodularis Treatment Revenue Market Share by Type (2017-2028)
Figure 20. North America Prurigo Nodularis Treatment Revenue Market Share by Application (2017-2028)
Figure 21. North America Prurigo Nodularis Treatment Revenue Share by Country (2017-2028)
Figure 22. U.S. Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Prurigo Nodularis Treatment Revenue Market Share by Company in 2021
Figure 25. Europe Prurigo Nodularis Treatment Revenue Market Share by Type (2017-2028)
Figure 26. Europe Prurigo Nodularis Treatment Revenue Market Share by Application (2017-2028)
Figure 27. Europe Prurigo Nodularis Treatment Revenue Share by Country (2017-2028)
Figure 28. Germany Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 29. France Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Prurigo Nodularis Treatment Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Prurigo Nodularis Treatment Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Prurigo Nodularis Treatment Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Prurigo Nodularis Treatment Revenue Share by Region (2017-2028)
Figure 37. China Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 40. India Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Prurigo Nodularis Treatment Revenue Market Share by Company in 2021
Figure 49. Latin America Prurigo Nodularis Treatment Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Prurigo Nodularis Treatment Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Prurigo Nodularis Treatment Revenue Share by Country (2017-2028)
Figure 52. Mexico Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Prurigo Nodularis Treatment Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Prurigo Nodularis Treatment Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Prurigo Nodularis Treatment Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Prurigo Nodularis Treatment Revenue Share by Country (2017-2028)
Figure 59. Turkey Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 61. UAE Prurigo Nodularis Treatment Revenue (2017-2028) & (US$ Million)
Figure 62. Johnson & Johnson Revenue Growth Rate in Prurigo Nodularis Treatment Business (2017-2022)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Prurigo Nodularis Treatment Business (2017-2022)
Figure 64. Pfizer Revenue Growth Rate in Prurigo Nodularis Treatment Business (2017-2022)
Figure 65. Teva Pharmaceutical Revenue Growth Rate in Prurigo Nodularis Treatment Business (2017-2022)
Figure 66. Bayer Revenue Growth Rate in Prurigo Nodularis Treatment Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed